Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2008, Article ID 875394, 5 pages
http://dx.doi.org/10.1155/2008/875394
Research Article

Serum Concentration of Interleukin-6 Is Increased Both in Active and Remission Stages of Pemphigus Vulgaris

1Department of Dermatology, Medical University of Lodz, 94-017 Lodz, Poland
2Laboratory of Immunochemical Research, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland
3Department of Immunodermatology, Medical University of Lodz, 94-017 Lodz, Poland

Received 24 January 2008; Accepted 11 May 2008

Academic Editor: Yona Keisari

Copyright © 2008 Joanna Narbutt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. C. Udey and J. R. Stanley, “Pemphigus—diseases of antidesmosomal autoimmunity,” Journal of the American Medical Association, vol. 282, no. 6, pp. 572–576, 1999. View at Publisher · View at Google Scholar
  2. C. Feliciani, P. Toto, P. Amerio et al., “In vitro and in vivo expression of interleukin-1a and tumor necrosis factor-a mRNA in pemphigus vulgaris: interleukin-1a and tumor necrosis factor-a are involved in acantholysis,” Journal of Investigative Dermatology, vol. 114, no. 1, pp. 71–77, 2000. View at Publisher · View at Google Scholar
  3. L. D'Auria, C. Bonifati, A. Mussi et al., “Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-a levels are significantly increased as compared to healthy subjects and correlate with disease activity,” European Cytokine Network, vol. 8, no. 4, pp. 383–387, 1997. View at Google Scholar
  4. E. López-Robles, E. Avalos-Díaz, E. Vega-Memije et al., “TNFa and IL-6 are mediators in the blistering process of pemphigus,” International Journal of Dermatology, vol. 40, no. 3, pp. 185–188, 2001. View at Publisher · View at Google Scholar
  5. M. D. Orlov, A. I. Chernyavsky, J. Arredondo, and S. A. Grando, “Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-α during induction of basal cell shrinkage and acantholysis,” Autoimmunity, vol. 39, no. 7, pp. 557–562, 2006. View at Publisher · View at Google Scholar
  6. A. Jacobi, G. Schuler, and M. Hertl, “Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-α inhibitor infliximab,” British Journal of Dermatology, vol. 153, no. 2, pp. 448–449, 2005. View at Publisher · View at Google Scholar
  7. E. H. Beutner and R. E. Jordon, “Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescence staining,” Proceedings of the Society for Experimental Biology and Medicine, vol. 117, pp. 505–510, 1964. View at Google Scholar
  8. C. Veldman, R. Eming, S. Wolff-Franke, G. Sonderstrup, W. W. Kwok, and M. Hertl, “Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DRβ10402 tetramers,” Clinical Immunology, vol. 122, no. 3, pp. 330–337, 2007. View at Publisher · View at Google Scholar
  9. M.-S. Lin, S. J. Swartz, A. Lopez et al., “Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris,” Journal of Clinical Investigation, vol. 99, no. 1, pp. 31–40, 1997. View at Publisher · View at Google Scholar
  10. H. Walter, S. Schepensn, J. van Wauwe, and M. de Boer, “Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines,” European Cytokine Network, vol. 5, no. 1, pp. 13–21, 1994. View at Google Scholar
  11. M. Aoki-Ota, K. Tsunoda, T. Ota et al., “A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice,” British Journal of Dermatology, vol. 151, no. 2, pp. 346–354, 2004. View at Publisher · View at Google Scholar
  12. K. Buschard, E. Dabelsteen, and P. Bretlau, “A model for the study of autoimmune diseases applied to pemphigus: transplants of human oral mucosa to athymic nude mice binds pemphigus antibodies in vivo,” Journal of Investigative Dermatology, vol. 76, no. 3, pp. 171–173, 1981. View at Publisher · View at Google Scholar
  13. C. Feliciani, P. Toto, B. Wang, D. N. Sauder, P. Amerio, and A. Tulli, “Urokinase plasminogen activator mRNA is induced by IL-1α and TNF-α in in vitro acantholysis,” Experimental Dermatology, vol. 12, no. 4, pp. 466–471, 2003. View at Publisher · View at Google Scholar
  14. M. Alecu, S. Alecu, G. Coman, E. Gălăţescu, and C. Ursaciuc, “ICAM-1, ELAM-1, TNF-α and IL-6 in serum and blister liquid of pemphigus vulgaris patients,” Roumanian Archives of Microbiology and Immunology, vol. 58, no. 2, pp. 121–130, 1999. View at Google Scholar
  15. C. Feliciani, P. Toto, and P. Amerio, “In vitro C3 mRNA expression in pemphigus vulgaris: complement activation is increased by IL-1α and TNF-α,” Journal of Cutaneous Medicine and Surgery, vol. 3, no. 3, pp. 140–144, 1999. View at Google Scholar
  16. K. Lacka, E. Manuszewska, I. Korczowska, and J. K. Lacki, “The effect of methylprednisolone pulse treatment on cytokine network in graves ophthalmopathy,” Current Eye Research, vol. 32, no. 3, pp. 291–297, 2007. View at Publisher · View at Google Scholar
  17. D. B. Keskin, J. N. H. Stern, M. Fridkis-Hareli, and A. R. Razzaque Ahmed, “Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy,” Cytokine, vol. 41, no. 3, pp. 315–321, 2008. View at Publisher · View at Google Scholar
  18. T. Gomi, T. Shiohara, T. Munakata, K. Imanishi, and M. Nagashima, “Interleukin 1α, tumor necrosis factor α, and interferon γ in psoriasis,” Archives of Dermatology, vol. 127, no. 6, pp. 827–830, 1991. View at Publisher · View at Google Scholar
  19. A. Wozniacka, A. Lesiak, J. Narbutt, D. P. McCauliffe, and A. Sysa-Jedrzejowska, “Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients,” Lupus, vol. 15, no. 5, pp. 268–275, 2006. View at Publisher · View at Google Scholar
  20. T. V. Kantor, D. Friberg, T. A. Medsger Jr., R. B. Buckingham, and T. L. Whiteside, “Cytokine production and serum levels in systemic sclerosis,” Clinical Immunology and Immunopathology, vol. 65, no. 3, pp. 278–285, 1992. View at Publisher · View at Google Scholar
  21. A. Köck, T. Schwarz, R. Kirnbauer et al., “Human keratinocytes are a source for tumor necrosis factor a: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light,” Journal of Experimental Medicine, vol. 172, no. 6, pp. 1609–1614, 1990. View at Publisher · View at Google Scholar
  22. K. C. Bhol, A. Desai, S. Kumari, J. E. Colon, and A. R. Ahmed, “Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production,” Clinical Immunology, vol. 100, no. 2, pp. 172–180, 2001. View at Publisher · View at Google Scholar
  23. P. Galle, M. Svenson, K. Bendtzen, and M. B. Hansen, “High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors,” European Journal of Immunology, vol. 34, no. 11, pp. 3267–3275, 2004. View at Publisher · View at Google Scholar
  24. K. C. Bhol, A. I. Rojas, I. U. Khan, and A. R. Ahmed, “Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid,” Cytokine, vol. 12, no. 7, pp. 1076–1083, 2000. View at Publisher · View at Google Scholar